Your browser doesn't support javascript.
loading
Divergent Molecular and Cellular Responses to Low and High-Dose Ionizing Radiation.
Sampadi, Bharath; Vermeulen, Sylvia; Misovic, Branislav; Boei, Jan J; Batth, Tanveer S; Chang, Jer-Gung; Paulsen, Michelle T; Magnuson, Brian; Schimmel, Joost; Kool, Hanneke; Olie, Cyriel S; Everts, Bart; Vertegaal, Alfred C O; Olsen, Jesper V; Ljungman, Mats; Jeggo, Penny A; Mullenders, Leon H F; Vrieling, Harry.
Affiliation
  • Sampadi B; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Vermeulen S; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Misovic B; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Boei JJ; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Batth TS; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
  • Chang JG; Department of Cell and Chemical Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Paulsen MT; Department of Radiation Oncology, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
  • Magnuson B; Department of Radiation Oncology, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
  • Schimmel J; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Kool H; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Olie CS; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Everts B; Department of Parasitology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
  • Vertegaal ACO; Department of Cell and Chemical Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Olsen JV; Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
  • Ljungman M; Department of Radiation Oncology, Rogel Cancer Center and Center for RNA Biomedicine, University of Michigan, Ann Arbor, MI 48109, USA.
  • Jeggo PA; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RQ, UK.
  • Mullenders LHF; Department of Human Genetics, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Vrieling H; Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya 464-8601, Japan.
Cells ; 11(23)2022 Nov 27.
Article in En | MEDLINE | ID: mdl-36497055
ABSTRACT
Cancer risk after ionizing radiation (IR) is assumed to be linear with the dose; however, for low doses, definite evidence is lacking. Here, using temporal multi-omic systems analyses after a low (LD; 0.1 Gy) or a high (HD; 1 Gy) dose of X-rays, we show that, although the DNA damage response (DDR) displayed dose proportionality, many other molecular and cellular responses did not. Phosphoproteomics uncovered a novel mode of phospho-signaling via S12-PPP1R7, and large-scale dephosphorylation events that regulate mitotic exit control in undamaged cells and the G2/M checkpoint upon IR in a dose-dependent manner. The phosphoproteomics of irradiated DNA double-strand breaks (DSBs) repair-deficient cells unveiled extended phospho-signaling duration in either a dose-dependent (DDR signaling) or independent (mTOR-ERK-MAPK signaling) manner without affecting signal magnitude. Nascent transcriptomics revealed the transcriptional activation of genes involved in NRF2-regulated antioxidant defense, redox-sensitive ERK-MAPK signaling, glycolysis and mitochondrial function after LD, suggesting a prominent role for reactive oxygen species (ROS) in molecular and cellular responses to LD exposure, whereas DDR genes were prominently activated after HD. However, how and to what extent the observed dose-dependent differences in molecular and cellular responses may impact cancer development remain unclear, as the induction of chromosomal damage was found to be dose-proportional (10-200 mGy).
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Radiation, Ionizing / DNA Breaks, Double-Stranded Language: En Journal: Cells Year: 2022 Type: Article Affiliation country: Netherlands

Full text: 1 Database: MEDLINE Main subject: Radiation, Ionizing / DNA Breaks, Double-Stranded Language: En Journal: Cells Year: 2022 Type: Article Affiliation country: Netherlands